Cash flow Telesis Bio, Inc.

Stocks

TBIO

US1920032000

Advanced Medical Equipment & Technology

Delayed OTC Markets Other stock markets 10:16:07 2026-06-09 am EDT			5-day change	1st Jan Change
0.001000 ^USD	+900.00%		-98.11%	-98.00%

25-05-28	Telesis Bio Inc. Announces Licensing Agreement with Regeneron Pharmaceuticals, Inc. to Adopt Gibson SOLA Platform for Rapid On-Site DNA and Gene Synthesis	CI
25-05-28	Telesis Bio Announces Licensing Agreement With Regeneron	RE

b1be6a7.xvuVWZO2X4nYl7j9iRESOY8g4U3t9164ruvOENxZvH4.pIzBEd6BG8qx7fq7x2J3V8BEtAW9nAzI6bKqe68ozi2AvNMB6oQK3Jzyyw

Published financial data: TELESIS BIO, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	5.77M	6.58M	11.04M	27.44M	27.51M
Total Revenues	5.77M	6.58M	11.04M	27.44M	27.51M
Cost of Goods Sold, Total	3.21M	2.95M	6.74M	11.84M	10.56M
Gross Profit	2.55M	3.62M	4.3M	15.6M	16.95M
Selling General & Admin Expenses, Total	6.94M	11.06M	24.82M	38.62M	34.6M
R&D Expenses	3.98M	8.92M	14.55M	23.46M	17.5M
Other Operating Expenses, Total	10.92M	19.99M	39.37M	62.08M	52.1M
Operating Income	-8.37M	-16.36M	-35.07M	-46.48M	-35.15M
Interest Expense, Total	-1.79M	-690K	-1.37M	-1.22M	-3.1M
Interest And Investment Income	-	-	-	-	1.74M
Net Interest Expenses	-1.79M	-690K	-1.37M	-1.22M	-1.36M
Other Non Operating Income (Expenses)	430K	-954K	-1.56M	-16K	337K
EBT, Excl. Unusual Items	-9.73M	-18M	-38M	-47.72M	-36.18M
Merger & Related Restructuring Charges	-	-	-300K	-	-
Impairment of Goodwill	-	-	-	-	-11.39M
Gain (Loss) On Sale Of Assets	-233K	-	-27K	-2K	-136K
Other Unusual Items	-	-	-618K	-727K	-
EBT, Incl. Unusual Items	-9.96M	-18M	-38.94M	-48.45M	-47.7M
Income Tax Expense	-	5K	14K	24K	24K
Earnings From Continuing Operations	-9.96M	-18.01M	-38.96M	-48.47M	-47.72M
Net Income to Company	-9.96M	-18.01M	-38.96M	-48.47M	-47.72M
Net Income - (IS)	-9.96M	-18.01M	-38.96M	-48.47M	-47.72M
Preferred Dividend and Other Adjustments	-	-	-	-	1.3M
Net Income to Common Incl Extra Items	-9.96M	-18.01M	-38.96M	-48.47M	-49.02M
Net Income to Common Excl. Extra Items	-9.96M	-18.01M	-38.96M	-48.47M	-49.02M
Per Share Items
Net EPS - Basic	-35.86	-64.82	-38.48	-29.61	-29.56
Basic EPS - Continuing Operations	-35.86	-64.82	-38.48	-29.61	-29.56
Basic Weighted Average Shares Outstanding	278K	278K	1.01M	1.64M	1.66M
Net EPS - Diluted	-35.86	-64.82	-38.48	-29.61	-29.56
Diluted EPS - Continuing Operations	-35.86	-64.82	-38.48	-29.61	-29.56
Diluted Weighted Average Shares Outstanding	278K	278K	1.01M	1.64M	1.66M
Normalized Basic EPS	-21.89	-40.5	-23.46	-18.22	-13.63
Normalized Diluted EPS	-21.89	-40.5	-23.46	-18.22	-13.63
Supplemental Items
EBITDA	-7.34M	-15.5M	-34.17M	-44.81M	-32.83M
EBITA	-7.88M	-15.9M	-34.62M	-45.97M	-34.64M
EBIT	-8.37M	-16.36M	-35.07M	-46.48M	-35.15M
EBITDAR	-5.62M	-15.14M	-33.69M	-41.83M	-26.67M
Total Revenues (As Reported)	5.77M	6.58M	11.04M	27.44M	27.51M
Effective Tax Rate - (Ratio)	-	-0.03	-0.04	-0.05	-0.05
Normalized Net Income	-6.08M	-11.25M	-23.75M	-29.82M	-22.61M
Interest on Long-Term Debt	-	17K	9K	3K	14K
Supplemental Operating Expense Items
Advertising Expense	100K	800K	900K	1M	700K
Selling and Marketing Expenses	2.25M	6.93M	10.9M	16.49M	13.51M
General and Administrative Expenses	4.69M	4.13M	13.93M	22.13M	21.09M
Research And Development Expense From Footnotes	3.98M	8.92M	14.55M	23.46M	17.5M
Net Rental Expense, Total	500K	350K	475K	2.99M	6.16M
Imputed Operating Lease Interest Expense	-	295K	406K	1.5M	5.49M
Imputed Operating Lease Depreciation	-	54.9K	69.34K	1.49M	677K
Stock-Based Comp., R&D Exp. (Total)	4.8K	13K	25K	582K	808K
Stock-Based Comp., S&M Exp. (Total)	1.2K	5K	93K	425K	398K
Stock-Based Comp., G&A Exp. (Total)	7.2K	25K	929K	2.72M	2.76M
Stock-Based Comp., Other (Total)	-	-	39K	-	-
Total Stock-Based Compensation	13.2K	43K	1.09M	3.73M	3.96M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	29.14M	13.46M	82.81M	30.42M	1.57M
Short Term Investments	-	-	-	13.16M	17.59M
Total Cash And Short Term Investments	29.14M	13.46M	82.81M	43.58M	19.16M
Accounts Receivable, Total	1.49M	2.27M	3.66M	5.85M	5.98M
Total Receivables	1.49M	2.27M	3.66M	5.85M	5.98M
Inventory	712K	601K	2.37M	2.2M	4.02M
Prepaid Expenses	86K	851K	4.34M	3.29M	1.01M
Restricted Cash	-	-	-	175K	175K
Total Current Assets	31.43M	17.18M	93.18M	55.09M	30.35M
Gross Property Plant And Equipment	1.25M	4.54M	6.53M	10.46M	37.99M
Accumulated Depreciation	-362K	-766K	-793K	-1.94M	-3.47M
Net Property Plant And Equipment	888K	3.78M	5.74M	8.52M	34.52M
Goodwill	3.5M	3.5M	14.33M	14.89M	3.5M
Other Intangibles, Total	2.86M	2.32M	2.4M	1.88M	1.37M
Other Long-Term Assets, Total	81K	81K	609K	981K	676K
Total Assets	38.76M	26.86M	116M	81.36M	70.41M
Liabilities
Accounts Payable, Total	614K	1.19M	2.5M	1.3M	3.28M
Accrued Expenses, Total	885K	1.69M	4.85M	7.24M	2.65M
Current Portion of Long-Term Debt	-	1.33M	603K	-	-
Current Portion of Leases	111K	783K	1.24M	637K	1.82M
Unearned Revenue Current, Total	112K	606K	205K	3.96M	338K
Other Current Liabilities	-	22K	335K	373K	92K
Total Current Liabilities	1.72M	5.62M	9.73M	13.5M	8.18M
Long-Term Debt	4.47M	3.35M	14.09M	19.65M	5.27M
Long-Term Leases	185K	2.86M	1.39M	1.14M	27.29M
Unearned Revenue Non Current	33K	40K	150K	142K	95K
Other Non Current Liabilities	938K	1.53M	108K	367K	36K
Total Liabilities	7.35M	13.41M	25.47M	34.8M	40.87M
Preferred Stock Convertible	38.91M	38.91M	-	-	29.3M
Total Preferred Equity	38.91M	38.91M	-	-	29.3M
Common Stock, Total	2K	2K	5K	5K	5K
Additional Paid In Capital	797K	851K	156M	160M	162M
Retained Earnings	-8.3M	-26.31M	-65.27M	-114M	-161M
Comprehensive Income and Other	-	-	-	-3K	-
Total Common Equity	-7.5M	-25.46M	90.78M	46.56M	238K
Total Equity	31.41M	13.46M	90.78M	46.56M	29.54M
Total Liabilities And Equity	38.76M	26.86M	116M	81.36M	70.41M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	278K	279K	1.63M	1.65M	1.67M
ECS Total Common Shares Outstanding	278K	279K	1.63M	1.65M	1.67M
Book Value / Share	-27.01	-91.21	55.74	28.27	0.14
Tangible Book Value	-13.86M	-31.28M	74.06M	29.8M	-4.63M
Tangible Book Value Per Share	-49.9	-112.07	45.47	18.09	-2.77
Total Debt	4.77M	8.33M	17.32M	21.43M	34.38M
Net Debt	-24.38M	-5.14M	-65.48M	-22.15M	15.22M
Debt Equivalent Oper. Leases	-	2.8M	3.8M	23.9M	49.31M
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	612K	299K	962K	1.04M	2.03M
Inventories - Work In Process, Total	167K	201K	896K	647K	1.03M
Inventories - Finished Goods, Total	13K	101K	510K	509K	968K
Machinery, Total	1.25M	1.32M	2.62M	7.24M	9.86M
Full Time Employees	-	91	212	223	137
Part Time Employees	-	-	24	20	10
Accumulated Allowance for Doubtful Accounts (Supple)	105K	105K	-	343K	1.29M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-9.96M	-18.01M	-38.96M	-48.47M	-47.72M
Depreciation & Amortization - CF	538K	994K	1.12M	2.36M	3.59M
Amortization of Goodwill and Intangible Assets - (CF)	491K	463K	458K	515K	515K
Depreciation & Amortization, Total	1.03M	1.46M	1.57M	2.88M	4.1M
Amortization of Deferred Charges, Total - (CF)	64.8K	214K	480K	482K	765K
(Gain) Loss From Sale Of Asset	233K	-	27K	2K	136K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-179K	-643K
Asset Writedown & Restructuring Costs	-	73K	-	-	11.63M
Stock-Based Compensation (CF)	13.2K	43K	1.09M	3.73M	3.96M
Provision and Write-off of Bad Debts	-	-	-	-	1.2M
Other Operating Activities, Total	685K	862K	2.13M	719K	-331K
Change In Accounts Receivable	-1.03M	-774K	-735K	-2.19M	-1.33M
Change In Inventories	868K	111K	-1.46M	168K	-1.82M
Change In Accounts Payable	278K	1.4M	4.39M	1.16M	-3.28M
Change in Unearned Revenues	-18K	501K	-542K	3.74M	-3.67M
Change in Other Net Operating Assets	173K	-1.26M	-4.69M	-759K	2.34M
Cash from Operations	-7.67M	-15.38M	-36.7M	-38.72M	-34.67M
Capital Expenditure	-94.8K	-204K	-1.85M	-4.47M	-1.98M
Sale of Property, Plant, and Equipment	-	-	-	-	16K
Cash Acquisitions	-	-	-13.19M	-556K	-
Investment in Marketable and Equity Securities, Total	-	-	-	-12.98M	-3.78M
Cash from Investing	-94.8K	-204K	-15.04M	-18.01M	-5.74M
Long-Term Debt Issued, Total	11.75M	-	14.87M	19.76M	-
Total Debt Issued	14.1M	-	14.87M	19.76M	-
Long-Term Debt Repaid, Total	-9.03M	-107K	-5.08M	-15.08M	-15.09M
Total Debt Repaid	-10.83M	-107K	-5.08M	-15.08M	-15.09M
Issuance of Common Stock	-	11K	121M	580K	240K
Issuance of Preferred Stock	39.54M	-	-	-	19.41M
Other Financing Activities, Total	-683K	-	-9.95M	-752K	7.01M
Cash from Financing	42.13M	-96K	121M	4.51M	11.56M
Foreign Exchange Rate Adjustments	-	-	-	-	-3K
Net Change in Cash	34.36M	-15.68M	69.34M	-52.21M	-28.85M
Supplemental Items
Cash Interest Paid	1.59M	464K	825K	1.38M	2.23M
Cash Income Tax Paid (Refund)	-	-	-	-	24K
Levered Free Cash Flow	-	-8.68M	-23.77M	-23.37M	-23.24M
Unlevered Free Cash Flow	-	-8.46M	-23.39M	-23.09M	-22.06M
Change In Net Working Capital	-	-470K	2.28M	-3.83M	6.18M
Net Debt Issued / Repaid	3.27M	-107K	9.79M	4.68M	-15.09M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-31.16	-30.63	-29.4	-28.95
Return on Total Capital	-	-35.29	-33.75	-33	-33.31
Return On Equity %	-	-80.28	-74.75	-70.58	-125.42
Return on Common Equity	-	109.28	-119.27	-70.58	-209.49
Margin Analysis
Gross Profit Margin %	44.29	55.12	38.93	56.84	61.62
SG&A Margin	120.42	168.2	224.8	140.77	125.79
EBITDA Margin %	-127.35	-235.63	-309.39	-163.35	-119.34
EBITA Margin %	-136.67	-241.76	-313.47	-167.56	-125.9
EBIT Margin %	-145.18	-248.8	-317.61	-169.44	-127.78
Income From Continuing Operations Margin %	-172.78	-273.87	-352.78	-176.68	-173.48
Net Income Margin %	-172.78	-273.87	-352.78	-176.68	-173.48
Net Avail. For Common Margin %	-172.78	-273.87	-352.78	-176.68	-178.21
Normalized Net Income Margin	-105.46	-171.12	-215.06	-108.71	-82.19
Levered Free Cash Flow Margin	-	-131.95	-215.22	-85.17	-84.47
Unlevered Free Cash Flow Margin	-	-128.64	-211.82	-84.15	-80.2
Asset Turnover
Asset Turnover	-	0.2	0.15	0.28	0.36
Fixed Assets Turnover	-	2.82	2.32	3.85	1.28
Receivables Turnover (Average Receivables)	-	3.5	3.72	5.77	4.65
Inventory Turnover (Average Inventory)	-	4.5	4.54	5.18	3.39
Short Term Liquidity
Current Ratio	18.25	3.05	9.57	4.08	3.71
Quick Ratio	17.79	2.8	8.88	3.66	3.07
Operating Cash Flow to Current Liabilities	-4.45	-2.73	-3.77	-2.87	-4.24
Days Sales Outstanding (Average Receivables)	-	104.58	98.02	63.3	78.52
Days Outstanding Inventory (Average Inventory)	-	81.42	80.34	70.41	107.59
Average Days Payable Outstanding	-	116.31	79.12	59.32	67.48
Cash Conversion Cycle (Average Days)	-	69.69	99.24	74.39	118.63
Long Term Solvency
Total Debt/Equity	15.18	61.88	19.08	46.02	116.39
Total Debt / Total Capital	13.18	38.23	16.02	31.51	53.79
LT Debt/Equity	14.83	46.15	17.05	44.65	110.22
Long-Term Debt / Total Capital	12.87	28.51	14.32	30.58	50.94
Total Liabilities / Total Assets	18.96	49.91	21.91	42.77	58.05
EBIT / Interest Expense	-4.68	-23.71	-25.62	-38.2	-11.32
EBITDA / Interest Expense	-4.11	-21.95	-24.61	-34.37	-8.59
(EBITDA - Capex) / Interest Expense	-4.16	-22.24	-25.96	-38.04	-9.23
Total Debt / EBITDA	-0.65	-0.55	-0.51	-0.51	-1.29
Net Debt / EBITDA	3.32	0.34	1.94	0.53	-0.57
Total Debt / (EBITDA - Capex)	-0.64	-0.54	-0.49	-0.46	-1.2
Net Debt / (EBITDA - Capex)	3.28	0.33	1.84	0.48	-0.53
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	14.05	67.93	148.44	0.27
Gross Profit, 1 Yr. Growth %	-	41.96	18.59	262.76	8.69
EBITDA, 1 Yr. Growth %	-	111.02	120.5	31.17	-26.74
EBITA, 1 Yr. Growth %	-	101.74	117.74	32.8	-24.66
EBIT, 1 Yr. Growth %	-	95.44	114.38	32.53	-24.38
Earnings From Cont. Operations, 1 Yr. Growth %	-	80.78	116.31	24.42	-1.54
Net Income, 1 Yr. Growth %	-	80.78	116.31	24.42	-1.54
Normalized Net Income, 1 Yr. Growth %	-	85.05	111.91	25.58	-24.19
Diluted EPS Before Extra, 1 Yr. Growth %	-	80.72	-40.63	-23.05	-0.17
Accounts Receivable, 1 Yr. Growth %	-	51.88	61.74	59.65	2.29
Inventory, 1 Yr. Growth %	-	-15.59	294.01	-7.09	82.95
Net Property, Plant and Equip., 1 Yr. Growth %	-	325.56	51.81	48.53	305.12
Total Assets, 1 Yr. Growth %	-	-30.7	332.78	-30.02	-13.46
Tangible Book Value, 1 Yr. Growth %	-	125.68	-336.75	-59.76	-115.52
Common Equity, 1 Yr. Growth %	-	239.32	-456.59	-48.71	-99.49
Cash From Operations, 1 Yr. Growth %	-	100.59	138.59	5.5	-10.46
Capital Expenditures, 1 Yr. Growth %	-	115.19	808.82	140.99	-55.68
Levered Free Cash Flow, 1 Yr. Growth %	-	-	173.91	-1.69	-2.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	176.5	-1.3	-4.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	38.39	104.25	57.83
Gross Profit, 2 Yr. CAGR %	-	-	29.75	107.41	98.56
EBITDA, 2 Yr. CAGR %	-	-	115.71	70.06	-1.97
EBITA, 2 Yr. CAGR %	-	-	109.59	70.05	0.03
EBIT, 2 Yr. CAGR %	-	-	104.69	68.56	0.11
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	97.75	64.05	10.68
Net Income, 2 Yr. CAGR %	-	-	97.75	64.05	10.68
Normalized Net Income, 2 Yr. CAGR %	-	-	97.62	63.13	-2.43
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	3.59	-32.41	-12.35
Accounts Receivable, 2 Yr. CAGR %	-	-	56.73	60.69	27.79
Inventory, 2 Yr. CAGR %	-	-	82.37	91.33	30.37
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	154.18	50.16	145.3
Total Assets, 2 Yr. CAGR %	-	-	73.19	74.03	-22.18
Tangible Book Value, 2 Yr. CAGR %	-	-	131.15	-2.4	-75.01
Common Equity, 2 Yr. CAGR %	-	-	247.85	35.24	-94.88
Cash From Operations, 2 Yr. CAGR %	-	-	118.77	58.65	-2.81
Capital Expenditures, 2 Yr. CAGR %	-	-	342.23	368	3.34
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	64.1	-1.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	65.2	-2.88
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	68.19	61.13
Gross Profit, 3 Yr. CAGR %	-	-	-	82.79	67.22
EBITDA, 3 Yr. CAGR %	-	-	-	82.75	28.44
EBITA, 3 Yr. CAGR %	-	-	-	80.02	29.64
EBIT, 3 Yr. CAGR %	-	-	-	77.08	29.03
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	69.45	38.38
Net Income, 3 Yr. CAGR %	-	-	-	69.45	38.38
Normalized Net Income, 3 Yr. CAGR %	-	-	-	69.9	26.36
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-6.19	-23.02
Accounts Receivable, 3 Yr. CAGR %	-	-	-	57.7	38.23
Inventory, 3 Yr. CAGR %	-	-	-	45.65	88.49
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	112.5	109.04
Total Assets, 3 Yr. CAGR %	-	-	-	28.04	37.88
Tangible Book Value, 3 Yr. CAGR %	-	-	-	29.06	-47.12
Common Equity, 3 Yr. CAGR %	-	-	-	83.77	-78.93
Cash From Operations, 3 Yr. CAGR %	-	-	-	71.55	31.11
Capital Expenditures, 3 Yr. CAGR %	-	-	-	261.22	113.31
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	38.87
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	37.65